SCHEMBL9481644

SCHEMBL9481644

C=CCO/N=C(/C(=O)NC1C(=O)N2C(C(=O)OC(c3ccccc3)c3ccccc3)=C(C=C)CS[C@H]12)c1csc(NC=O)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 7/20 0.55
▸ APAF1 O14727 2/20 0.55
▸ APEX1 P27695 2/20 0.55
▸ LMNA P02545 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ PLCG1 P19174 1/20 0.55
▸ ABCC2 Q92887 1/20 0.55
▸ SIRT5 Q9NXA8 1/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ PSMD14 O00487 1/20 0.55
▸ MMP2 P08253 1/20 0.55
▸ MAPT P10636 4/20 0.49
▸ ABCC4 O15439 1/20 0.49
▸ CNR1 P21554 1/20 0.49
▸ CTDSP1 Q9GZU7 1/20 0.49
▸ PKM P14618 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ DUSP3 P51452 1/20 0.42
▸ PTPN5 P54829 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9481649 1.00 TDP1 (0.55) TDP1APAF1APEX1LMNATSHR
SCHEMBL9481483 0.95 TDP1 (0.55) TDP1APAF1APEX1LMNATSHR
SCHEMBL9481494 0.95 TDP1 (0.55) TDP1APAF1APEX1LMNATSHR
SCHEMBL9481209 0.94 TDP1 (0.57) TDP1APAF1APEX1LMNATSHR
SCHEMBL9481213 0.94 TDP1 (0.57) TDP1APAF1APEX1LMNATSHR
SCHEMBL9743767 0.93 APAF1 (0.55) TDP1APAF1APEX1LMNATSHR
SCHEMBL9743760 0.93 APAF1 (0.55) TDP1APAF1APEX1LMNATSHR
SCHEMBL9482611 0.92 TDP1 (0.54) TDP1APAF1APEX1LMNATSHR
SCHEMBL9482607 0.92 TDP1 (0.54) TDP1APAF1APEX1LMNATSHR
SCHEMBL9482885 0.92 TDP1 (0.52) TDP1APAF1APEX1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5252731-A Antibiotics FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-10-12 — — US disclosed
US-5110921-A Bactericides FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-05-05 — — US disclosed
US-4960889-A CEPHALOSPORIN INTERMEDIATES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-10-02 — — US disclosed
US-4731443-A 7-acylamino-3-vinylcephalosporanic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-03-15 — — US disclosed
EP-0244637-A1 Starting compounds for 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-11-11 — — EP disclosed
US-4585860-A ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-29 — — US disclosed
US-4487927-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-12-11 — — US disclosed
EP-0123024-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
US-4423213-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-12-27 — — US disclosed
US-4409214-A Including cefixime; antibiotics FUJISAWA PHARMACEUTICAL, CO., LTD. (JP) 1983-10-11 — — US disclosed
EP-0030630-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-24 — — EP disclosed
Send feedback